Ciprofibrate
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Ciprofibrate
Description :
Ciprofibrate (Win35833) is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha[1]. Ciprofibrate acts as an orally active hypolipidaemic agent and can be used for the research of primary hyperlipidaemias[2].Product Name Alternative :
Win35833UNSPSC :
12352005Hazard Statement :
H350Target :
PPARType :
Reference compoundRelated Pathways :
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear ReceptorApplications :
Cancer-programmed cell deathField of Research :
Metabolic DiseaseAssay Protocol :
https://www.medchemexpress.com/Ciprofibrate.htmlConcentration :
10mMPurity :
99.93Solubility :
DMSO : ≥ 100 mg/mLSmiles :
CC(C)(OC1=CC=C(C2C(Cl)(Cl)C2)C=C1)C(O)=OMolecular Formula :
C13H14Cl2O3Molecular Weight :
289.15Precautions :
H350References & Citations :
[1]Passilly, P., et al., Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate. Biochem Pharmacol, 1999. 58 (6) : p. 1001-8.|[2]Agnes M Rimando, et al. Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem. 2005 May 4;53 (9) :3403-7.|[3]Thing-Fong Tzeng, et al. 6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism. Nutrients. 2015 Feb 4;7 (2) :999-1020.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
LaunchedIsoform :
PPARαCAS Number :
[52214-84-3]

